Kolexia
Rousseau-Bussac Gaelle
Pneumologie
Centre Hospitalier Intercommunal Créteil
Créteil, France
77 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome pulmonaire non à petites cellules Tumeurs du poumon Carcinome pulmonaire à petites cellules Syndrome de perfusion du propofol Adénocarcinome Carcinome épidermoïde Anémie Carcinomes Adénocarcinome pulmonaire

Industries

Takeda Pharmaceutical
6 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2023
Pfizer
3 collaboration(s)
Dernière en 2023

Dernières activités

Efficacité et tolérance du sotarasib chez les patients porteurs d’un cancer bronchique non à petites cellules avec une mutation KRAS G12 C : résultats de l’étude en vie réelle IFCT-2102 Lung KG12Ci
28e Congrès de Pneumologie de Langue Française   01 janvier 2024
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Essai Clinique (Razor Genomics)   20 décembre 2023
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Targeted oncology   15 novembre 2023
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   02 novembre 2023
1400P Real-world effectiveness and safety of sotorasib in patients with KRAS G12C mutated metastatic non-small cell lung cancer (NSCLC): Results of the IFCT-2102 Lung KG12Ci study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1508TiP The 1920-EORTC-BIORADON study: Molecular characterization of non-small cell lung cancer (NSCLC) and indoor radon exposure in Europe
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
ICU admission for solid cancer patients treated with immune checkpoint inhibitors.
Annals of intensive care   18 avril 2023
CoStemCells: Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
Essai Clinique (Centre Hospitalier Intercommunal Creteil)   06 mars 2023
Erratum to "When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study" Bull. Cancer 109 (2022) 916-24.
Bulletin du cancer   17 février 2023